AIA Reviews Are A Game-Changer For Pharma, Survey Shows
The new proceedings for challenging patents under the America Invents Act have shaken up the biotechnology and pharmaceutical industries, with 78 percent of in-house counsel at such companies saying in a...To view the full article, register now.
Already a subscriber? Click here to view full article